truMED: Funding, Investors & Team (Sep 2026)
truMED is an A.I.-powered Digital Therapeutics that will facilitate this need while improving outcomes, containing costs, and reinventing the way care is delivered and received. It was founded in 2019 and is based in Southlake, Texas.
truMED has raised $500k across 1 funding round on record, the most recent a Seed of $500k announced in Apr 2021.
That round is below the $5.8M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
truMED Company Profile and Key Stats
Latest funding round on record: Apr 2021.
truMED Funding Rounds
truMED Founders and Leadership Team
No contact details are on record for this team yet.
truMED Funding Compared to Other Artificial Intelligence Startups
truMED's latest round of $500k is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like truMED in Artificial Intelligence and Southlake
Companies Similar to truMED
Positron provides hardware for implementing Transformer Model Inference in generative AI systems. The…
Clay creates automation tools that improve data quality and streamline outreach efforts for sales and…
WINT - Water Intelligence developing advanced solutions for smart water management and control. The company…
KingsCrowd is an online private market rating and analytics platform for equity crowdfunding research and…
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
truMED Funding FAQs
What does truMED do?
truMED is an A.I.-powered Digital Therapeutics that will facilitate this need while improving outcomes, containing costs, and reinventing the way care is delivered and received. It was founded in 2019 and is based in Southlake, Texas.
How much funding has truMED raised?
truMED has raised $500k across 1 round on record. The most recent is a Seed of $500k announced in Apr 2021.
When did truMED last raise funding?
truMED's most recent funding round on record is a Seed of $500k, announced in Apr 2021.
Who is the CEO of truMED?
Kelly Ladner is listed as CEO at truMED.
Where is truMED headquartered?
truMED is based in Southlake, Texas, United States.
How many employees does truMED have?
truMED is in the 11-50 employee band.
How does truMED's funding compare to other Artificial Intelligence startups?
truMED's latest round of $500k is below the $5.8M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's truMED Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for truMED is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.